III型血管前置的产前诊断与产后结局:系统综述
该系统综述共纳入18例III型血管前置,其中16例产前经阴道超声诊断(平均孕29周),15/18例(83.3%)合并至少一种胎盘异常;产前诊断者均活产并经剖宫产分娩,无新生儿并发症。作者建议对普通孕妇尤其低置或形态异常胎盘及辅助生殖受孕者行经阴道超声系统筛查。
要点
- III型血管前置产前诊断平均孕29周,经阴道超声是诊断方法。
- 83.3%(15/18)病例合并至少一种胎盘异常,包括低置插入、副叶、帆状或边缘插入。
- 产前诊断者均活产,剖宫产分娩中位孕35周,无新生儿并发症。
核心结论
- III型血管前置产前诊断具有挑战性且文献报道少,但对在胎膜破裂前择期剖宫产以降低不良结局风险至关重要。
- 作者建议对普通孕妇行经阴道超声系统筛查,尤其低置或形态异常胎盘及辅助生殖技术受孕者。
研究设计与样本
- 系统综述,按照PRISMA指南检索PubMed、MEDLINE和EMBASE自建库至2023年3月,并检索本中心超声数据库补充未发表病例。
- 共纳入18例III型血管前置,其中16例产前诊断(14例来自10篇文献,2例为本中心未发表病例),2例产后诊断(来自2篇文献)。
- 纳入研究质量采用美国国立卫生研究院病例系列研究质量评估工具评价。
关键影像表现/征象
- 产前病例均经阴道超声诊断,平均孕29周(中位31周,范围19-38周)。
- 15/18例(83.3%)观察到至少一种胎盘异常:低置插入9/17、副叶或附属叶1/17、帆状脐带插入3/18、边缘插入9/18。
诊断标准与关键数值
- III型血管前置定义为异常血管从胎盘延伸至羊膜,靠近宫颈内口后再返回胎盘,不一定合并其他胎盘或血管异常。
临床应用与阅片要点
- 产前诊断者均活产,均在胎膜破裂前剖宫产分娩,中位孕35周(范围32-38周),无新生儿并发症。
- 产前诊断组急诊剖宫产2/16例(12.5%),产后诊断组1/2例(50.0%),P=0.179。
- 1分钟Apgar评分≤7分:产前诊断组5/13例,产后诊断组1/1例;5分钟Apgar评分≤7分:产前诊断组3/13例,产后诊断组1/1例。
局限性
- 文献中III型血管前置病例报道少,产前诊断具有挑战性。
- 临床表现和危险因素非特异,脐带插入正常或单胎盘团块时不能排除III型血管前置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Type-III vasa previa (VP) is a rare form of VP, not necessarily associated with other placental or vascular anomalies, in which aberrant vessels run from the placenta to the amniotic membranes, near the internal cervical os, before returning to the placenta. Early diagnosis of Type-III VP is important but technically challenging. The objective of this study was to gather the current available evidence on the perinatal diagnosis and outcome of Type-III VP.
METHODS: A systematic review of the literature on the perinatal diagnosis of atypical Type-III VP was carried out in PubMed, MEDLINE and EMBASE accordingto PRISMA guidelines from inception to March 2023. Data extraction and tabulation were performed by two operators and checked by a third senior author. The quality of the included studies was evaluated using the National Institutes of Health tool for the quality assessment of case-series studies. Our local ultrasound database was searched for previously unreported recent cases. Characteristics of prenatally and postnatally diagnosed Type-III VP, including clinical features and perinatal outcomes, were summarized using descriptive statistics.
RESULTS: Eighteen cases of Type-III VP were included, of which 16 were diagnosed prenatally (14 cases were retrieved from 10 publications and two were unpublished cases from our center) and two were diagnosed postnatally (retrieved from two publications). All prenatal cases were diagnosed on transvaginal ultrasound at a mean gestational age of 29 weeks (median, 31 weeks; range, 19-38 weeks). Conception was achieved with in-vitro fertilization in 4/16 (25.0%) cases. There were no prenatal symptoms in 15/18 (83.3%) cases, while in two (11.1%) cases there was vaginal bleeding and in one (5.6%) preterm labor occurred. In 15/18 (83.3%) cases, at least one placental abnormality was observed, including low-lying insertion (9/17), succenturiate or accessory lobe (1/17), velamentous cord insertion (3/18) and marginal insertion (9/18). All prenatally diagnosed cases were liveborn and were delivered by Cesarean section before rupture of membranes at a median gestational age of 35 weeks (range, 32-38 weeks) without neonatal complications. Emergency Cesarean section was performed in 2/16 (12.5%) cases with a prenatal diagnosis and 1/2 (50.0%) cases with a postnatal diagnosis (P = 0.179). Among those with data available, an Apgar score of ≤ 7 was observed in the prenatally vs postnatally diagnosed group in 5/13 vs 1/1 cases, respectively, at the 1-min evaluation and 3/13 vs 1/1 cases, respectively, at the 5-min evaluation.
CONCLUSIONS: The prenatal diagnosis of Type-III VP is challenging, with few cases reported in the literature; however, it is crucial for minimizing the risk of adverse outcome by enabling early-term elective Cesarean delivery prior to rupture of membranes. Given that clinical manifestations and risk factors are non-specific, and that Type-III VP cannot be excluded when there is a normal cord insertion or a singular placental mass, systematic screening by transvaginal ultrasound in the general pregnant population is recommended, particularly in those with a low-lying or morphologically abnormal placenta and those who conceived using assisted reproductive technology. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Pozzoni M, Sammaria C, Villanacci R, et al. Prenatal diagnosis and postnatal outcome of Type-III vasa previa: systematic review of literature. Ultrasound Obstet Gynecol. 2024. PMID: 37470694. doi:10.1002/uog.26315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。